Nektar Therapeutics (NKTR)
(Delayed Data from NSDQ)
$1.50 USD
-0.15 (-9.09%)
Updated May 7, 2024 04:00 PM ET
After-Market: $1.68 +0.18 (12.00%) 7:58 PM ET
3-Hold of 5 3
D Value B Growth F Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/09/2024
Time: AMC |
3/2024 | $-0.21 | 0.00% |
Earnings Summary
For their last quarter, Nektar Therapeutics (NKTR) reported earnings of -$0.22 per share, missing the Zacks Consensus Estimate of -$0.20 per share. This reflects a negative earnings surprise of 10.00%. Look out for NKTR's next earnings release on May 09, 2024. For the next earning release, we expect the company to report earnings of -$0.21 per share, reflecting a year-over-year increase of 16%.
Earnings History
Price & Consensus
Zacks News for NKTR
Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata
NKTR: What are Zacks experts saying now?
Zacks Private Portfolio Services